4//SEC Filing
King Rachel K. 4
Accession 0000950170-24-127074
CIK 0001680581other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:15 PM ET
Size
5.2 KB
Accession
0000950170-24-127074
Insider Transaction Report
Form 4
King Rachel K.
Director
Transactions
- Award
Stock Option (right to buy)
2024-11-12+60,000→ 60,000 totalExercise: $3.64Exp: 2034-11-11→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This option was granted on November 12, 2024 and is scheduled to vest in equal monthly installments until November 12, 2027, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001589712
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:15 PM ET
- Size
- 5.2 KB